• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多发性骨髓瘤。五十例病例分析。

Multiple myeloma. Analysis of fifty cases.

作者信息

Venugopal P, Rajni A, Gopal R, Nair C N, Kurkure P A, Saikia T K, Nadkarni K S, Pai S K, Pai V R, Advani S H

出版信息

J Assoc Physicians India. 1989 Jun;37(6):367-70.

PMID:2592326
Abstract

Fifty patients of multiple myeloma have been studied. Seventy eight per cent of the patients were in the 5th, 6th and 7th decades of life. Commonest presenting feature was bone pains (76%). 8%, 20% belonged to stage I, II and III respectively. Skull (58%), ribs (52%) and pelvis (24%) were most commonly involved. Immunoelectrophoresis revealed IgG type of myeloma in 76% and IgA type in 10% cases. Bence-Jones proteinuria was seen in 60% of patients; Kappa specificity was commoner than lambda. Overall survival at 30 months was 50%. The survival was adversely influenced by advanced stage, higher plasma cell count in the bone marrow, low haemoglobin and high serum creatinine values.

摘要

对50例多发性骨髓瘤患者进行了研究。78%的患者年龄在50至70岁之间。最常见的临床表现是骨痛(76%)。分别有8%、20%的患者属于Ⅰ期、Ⅱ期和Ⅲ期。最常受累的部位是颅骨(58%)、肋骨(52%)和骨盆(24%)。免疫电泳显示,76%的病例为IgG型骨髓瘤,10%为IgA型。60%的患者出现本周蛋白尿;κ轻链比λ轻链更常见。30个月时的总生存率为50%。晚期、骨髓浆细胞计数较高、血红蛋白水平低和血清肌酐值高对生存率有不利影响。

相似文献

1
Multiple myeloma. Analysis of fifty cases.多发性骨髓瘤。五十例病例分析。
J Assoc Physicians India. 1989 Jun;37(6):367-70.
2
High dose chemotherapy followed by autologous haemopoietic stem cell transplant in multiple myeloma.大剂量化疗后自体造血干细胞移植治疗多发性骨髓瘤
Natl Med J India. 2003 Jan-Feb;16(1):16-21.
3
[Results of treatment of patients with advanced multiple myeloma with the vincristine-adriamycin-dexamethasone protocol].[采用长春新碱-阿霉素-地塞米松方案治疗晚期多发性骨髓瘤患者的结果]
Srp Arh Celok Lek. 1996 Nov-Dec;124(11-12):292-6.
4
Abnormal cytogenetics predict poor survival after high-dose therapy and autologous blood cell transplantation in multiple myeloma.异常细胞遗传学预示着多发性骨髓瘤患者在接受大剂量治疗和自体血细胞移植后的生存率较低。
Bone Marrow Transplant. 1999 Sep;24(5):497-503. doi: 10.1038/sj.bmt.1701943.
5
Long-term follow-up after high-dose therapy for high-risk multiple myeloma.高危多发性骨髓瘤大剂量治疗后的长期随访
Bone Marrow Transplant. 1998 Jun;21(11):1101-7. doi: 10.1038/sj.bmt.1701182.
6
Multiple myeloma in Ethiopians: analysis of 22 cases.埃塞俄比亚人的多发性骨髓瘤:22例病例分析。
Ethiop Med J. 1992 Jul;30(3):143-9.
7
Immunochemical studies in multiple myeloma.多发性骨髓瘤的免疫化学研究。
Indian J Cancer. 1997 Dec;34(4):151-8.
8
[Multiple myeloma].[多发性骨髓瘤]
Rinsho Ketsueki. 1989 Aug;30(8):1212-5.
9
Standard chemotherapy compared with high-dose chemoradiotherapy for multiple myeloma: final results of phase III US Intergroup Trial S9321.标准化疗与大剂量放化疗治疗多发性骨髓瘤的比较:美国国际协作组III期试验S9321的最终结果
J Clin Oncol. 2006 Feb 20;24(6):929-36. doi: 10.1200/JCO.2005.04.5807. Epub 2006 Jan 23.
10
[Multiple myeloma of bones. Retrospective study of prognostic factors based on a series of 243 patients].[骨多发性骨髓瘤。基于243例患者的系列研究对预后因素的回顾性分析]
Rev Rhum Mal Osteoartic. 1979 Feb;46(2):77-83.

引用本文的文献

1
PLASMA CELL MYELOMA PRESENTING AS ACUTE CONSTIPATION.以急性便秘为表现的浆细胞骨髓瘤
Med J Armed Forces India. 1997 Oct;53(4):305-306. doi: 10.1016/S0377-1237(17)30762-1. Epub 2017 Jun 26.